Overview

Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study was intended to evaluate the safety and efficacy of intravenous (IV) ACZ885 and oral methotrexate (MTX) therapy in patients with early rheumatoid arthritis (RA)
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Antibodies
Antibodies, Monoclonal
Methotrexate